BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6890837)

  • 1. The influence of a mistletoe preparation on suspension cell cultures of human leukemia and human myeloma cells.
    Hülsen H; Mechelke F
    Arzneimittelforschung; 1982; 32(9):1126-7. PubMed ID: 6890837
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the effects of various clinically applied mistletoe preparations on peripheral blood leukocytes.
    Elsässer-Beile U; Lusebrink S; Grussenmeyer T; Wetterauer U; Schultze-Seemann W
    Arzneimittelforschung; 1998 Dec; 48(12):1185-9. PubMed ID: 9893935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mistletoe therapy. An alternative cancer treatment].
    Ernst E
    MMW Fortschr Med; 2000 Nov; 142(45):52-3. PubMed ID: 11107826
    [No Abstract]   [Full Text] [Related]  

  • 4. [Value of mistletoe therapy in carcinoma patients].
    Rostock M; Unger C
    Internist (Berl); 1998 Dec; 39(12):1294-5. PubMed ID: 10198836
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening of Philippine medicinal plants for anticancer agents using CCNSC Protocols.
    Masilungan VA; Vadlamudi S; Goldin A
    Cancer Chemother Rep 2; 1971 Apr; 2(1):135-40. PubMed ID: 5109412
    [No Abstract]   [Full Text] [Related]  

  • 6. Differences in the in vitro effectiveness of preparations produced from mistletoes of various host trees.
    Hülsen H; Doser C; Mechelke F
    Arzneimittelforschung; 1986 Mar; 36(3):433-6. PubMed ID: 3707661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effects of mistletoe extracts and mistletoe lectins. Cytotoxicity towards tumor cells due to the induction of programmed cell death (apoptosis).
    Janssen O; Scheffler A; Kabelitz D
    Arzneimittelforschung; 1993 Nov; 43(11):1221-7. PubMed ID: 8292069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reactions of in vitro cultures of human fibroblasts, of HeLa-cells and of murine L-cells on application of a drug from Viscum album L. (author's transl)].
    Ulrich W; Mechelke F
    Arzneimittelforschung; 1980; 30(10):1722-5. PubMed ID: 7192110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative and anticarcinogenic effects of an aqueous preparation of Abies alba and Viscum album se abies, on a L-1210 malignant cell line and tumor-bearing Wistar rats.
    Karkabounas S; Assimakopoulos D; Malamas M; Skaltsounis AL; Leonce S; Zelovitis J; Stefanou D; Evangelou A
    Anticancer Res; 2000; 20(6B):4391-5. PubMed ID: 11205277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumour activity of the extract of Semecarpus anacardium L. nuts in experimental tumor models.
    Chitnis MP; Bhatia KG; Phatak MK; Kesava Rao KV
    Indian J Exp Biol; 1980 Jan; 18(1):6-8. PubMed ID: 7399581
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of advanced pancreatic cancer with mistletoe: results of a pilot trial.
    Friess H; Beger HG; Kunz J; Funk N; Schilling M; Büchler MW
    Anticancer Res; 1996; 16(2):915-20. PubMed ID: 8687151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent studies on the anticancer activities of mistletoe (Viscum album) and its alkaloids.
    Khwaja TA; Dias CB; Pentecost S
    Oncology; 1986; 43 Suppl 1():42-50. PubMed ID: 3543783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumoral effects of an intravesically applied aqueous mistletoe extract on urinary bladder carcinoma MB49 in mice.
    Mengs U; Schwarz T; Bulitta M; Weber K
    Anticancer Res; 2000; 20(5B):3565-8. PubMed ID: 11131663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Favorable long-term outcome with mistletoe therapy in a patient with centroblastic-centrocytic non hodgkin lymphoma].
    Pierach CA
    Dtsch Med Wochenschr; 2000 Aug; 125(31-32):958-60. PubMed ID: 10967963
    [No Abstract]   [Full Text] [Related]  

  • 15. Plant anticancer agents. VIII. Constituents of Inga punctata.
    Kingston DG; Munjal RC
    Lloydia; 1978; 41(5):499-500. PubMed ID: 713710
    [No Abstract]   [Full Text] [Related]  

  • 16. Mistletoe extracts standardized to mistletoe lectins in oncology: review on current status of preclinical research.
    Mengs U; Göthel D; Leng-Peschlow E
    Anticancer Res; 2002; 22(3):1399-407. PubMed ID: 12168816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the antileukemic principle of Maytenus guangsiensis Cheng et Sha (author's transl)].
    Qian X; Gai C; Yao S
    Yao Xue Xue Bao; 1979; 14(3):182. PubMed ID: 506724
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of a standardized mistletoe preparation on metastatic B16 melanoma colonization in murine lungs.
    Weber K; Mengs U; Schwarz T; Hajto T; Hostanska K; Allen TR; Weyhenmeyer R; Lentzen H
    Arzneimittelforschung; 1998 May; 48(5):497-502. PubMed ID: 9638318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer activity of the extracts of root, stem & leaf of Ervatamia heyneana.
    Chitnis MP; Khandalekar DD; Adwankar MK; Sahasrabudhe MB
    Indian J Exp Biol; 1971 Apr; 9(2):268-70. PubMed ID: 5092749
    [No Abstract]   [Full Text] [Related]  

  • 20. Human cancer cells exhibit in vitro individual receptiveness towards different mistletoe extracts.
    Knöpfl-Sidler F; Viviani A; Rist L; Hensel A
    Pharmazie; 2005 Jun; 60(6):448-54. PubMed ID: 15997835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.